Detalhe da pesquisa
1.
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells.
Clin Infect Dis
; 67(4): 533-540, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481659